항암화학요법을 받는 혈액암 환자의 증상경험, 사회적 지지와 삶의 질
Symptom Experience, Social Support, and Quality of Life in Patients with Hematologic Malignancies Undergoing Chemotherapy
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to identify symptom experience, social support, quality of life (QOL), and the influencing factors on QOL of patients with hematologic malignancies undergoing chemotherapy. Methods: A cross-sectional study was conducted on 118 patients diagnosed with hematologic malignancies undergoing chemotherapy who visited an outpatient clinic in the Gyeonggi province. The Functional Assessment of Cancer Therapy-General (FACT-G), MD Anderson Symptom Inventory (MDASI), and the Multidimensional Scale of Perceived Social Support (MSPSS) were used to assess predictors and QOL. The data were analyzed using the Pearson correlation, t-test, ANOVA, and hierarchical multiple regression. Results: The mean score of QOL was (69.32±14.34). The type of hematologic malignancies and patient’s occupation were significantly associated with QOL in terms of demographic and disease/treatment-related characteristics. Symptom severity and symptom influence, and the support of family, friends, and medical staff had a significant association with QOL. The regression analyses showed that symptom severity (β=-.41, p<.001), friend support (β=.27, p=.001), and occupation (β=.14, p=.034) were significantly associated with QOL. Conclusion: The variables of symptom experience and social support must be acknowledged when improving QOL of hematologic malignancy patients undergoing chemotherapy. Greater focus on the reduction of symptom severity and increasing friend support could improve QOL among hematologic malignancy patients.
Abstract
Purpose: The purpose of this study was to identify symptom experience, social support, quality of life (QOL), and the influencing factors on QOL of patients with hematologic malignancies undergoing chemotherapy. Methods: A cross-sectional study was conducted on 118 patients diagnosed with hematologic malignancies undergoing chemotherapy who visited an outpatient clinic in the Gyeonggi province. The Functional Assessment of Cancer Therapy-General (FACT-G), MD Anderson Symptom Inventory (MDASI), and the Multidimensional Scale of Perceived Social Support (MSPSS) were used to assess predictors and QOL. The data were analyzed using the Pearson correlation, t-test, ANOVA, and hierarchical multiple regression. Results: The mean score of QOL was (69.32±14.34). The type of hematologic malignancies and patient’s occupation were significantly associated with QOL in terms of demographic and disease/treatment-related characteristics. Symptom severity and symptom influence, and the support of family, friends, and medical staff had a significant association with QOL. The regression analyses showed that symptom severity (β=-.41, p<.001), friend support (β=.27, p=.001), and occupation (β=.14, p=.034) were significantly associated with QOL. Conclusion: The variables of symptom experience and social support must be acknowledged when improving QOL of hematologic malignancy patients undergoing chemotherapy. Greater focus on the reduction of symptom severity and increasing friend support could improve QOL among hematologic malignancy patients.
참고문헌 (30)
- "Korea Central Cancer Registry. Cancer Registration Statistics Press Release in Korea 2019"[URL]
- "Korea Central Cancer Registry. Annual report of cancer statistics in Korea in 2018"[URL]
- Döhner H, "Acute myeloid leukemia", N Engl J Med, 373, pp.1136~1152 (2015)
- 김수경, "혈액암환자의 자기효능감, 자가간호행위와 삶의 질의 관계", 석사, 간호학과 종양전문간호전공, pp.2013
- Cherwin CH, "Distress-based gastrointestinal symptom clusters and impact on symptom interference and quality of life in patients with a hematologic malignancy receiving chemotherapy", J Pain Symptom Manage, 53, pp.751~758 (2017)
- Breen S, "The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling realtime monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial", Trials, 16, pp.472~ (2015)
- Senf B, "Quality of life and distress assessed with self and external assessment screening tools in patients with hematologic malignancies attending treatment in an acute hospital", Qual Life Res, 29, pp.3375~3385 (2020)
- Geue K, "Perceived social support and associations with healthrelated quality of life in young versus older adult patients with haematological malignancies", Health Qual Life Outcomes, 17, pp.145~ (2019)
- Nørskov KH, "Patients’experiences and social support needs following the diagnosis and initial treatment of acute leukemia-a qualitative study", Eur J Oncol Nurs, 41, pp.49~55 (2019)
- Pulgar Á, "Psychosocial predictors of quality of life in hematological cancer", Behav Med, 41, pp.1~8 (2015)
- The Korean Society of Hematology, "Hematology" (2011), Bubmoon Education
- 이영신, "혈액암환자 배우자의 돌봄 경험: 끝이 없는 터널에서 나오는 길 찾기", Asian Oncology Nursing, 16(1), pp.46~57 (2016), 대한종양간호학회
- Oberoi DV, "Distress and unmet needs during treatment and quality of life in early cancer survivorship : a longitudinal study of haematological cancer patients", Eur J Haematol, 99, pp.423~430 (2017)
- Allart P, "Are psychosocial factors associated with quality of life in patients with haematological cancer? A critical review of the literature", Psychooncology, 22, pp.241~249 (2013)
- 정지연, "항암화학요법을 받은 입원 암환자의 삶의 질에 영향을 미치는 요인", Asian Oncology Nursing, 12(1), pp.84~91 (2012), 대한종양간호학회
- Cleeland CS, "Assessing symptom distress in cancer patients. the MD Anderson symptom inventory", Pain Pract, 1, pp.207~ (2000)
- Yun YH, "Validation study of the Korean version of the M. D. Anderson symptom inventory", J Pain Symptom Manage, 31, pp.345~352 (2006)
- Zimet GD, "The multidimensional scale of perceived social support", J Pers Assess, 52, pp.30~41 (1988)
- Shin JS, "The effects of social supports on psychosocial well-being of the unemployed", Korean J Soc Welf, 37, pp.241~269 (1999)
- Cella DF, "The functional assessment of cancer therapy scale : development and validation of the general measure", J Clin Oncol, 11, pp.570~579 (1993)
- 김환, "Functional Assessment Cancer Therapy-General(FACT-G)의 한국판 개발 및 타당화", Korean Journal of Clinical Psychology, 22(1), pp.215~229 (2003), 한국임상심리학회
- 오복자, "대장암환자의 항암화학요법 관련 인지손상과 삶의 질: 심리적 디스트레스(우울·불안)의 매개효과", Journal of Korean Academy of Nursing, 46(1), pp.19~28 (2016), 한국간호과학회
- Ko AR, "A model for quality of life in lung cancer survivors based on the theory of symptom self-management", master, pp.2015
- Hui D, "Quality of end-of-life care in patients with hematologic malignancies : a retrospective cohort study", Cancer, 120, pp.1572~1578 (2014)
- Lee AR, "An explanatory model on quality of life in patients with hematologic malignancy", doctor, pp.2015
- Son DH, "The symptom experience and supportive care needs of hematologic malignancy survivors with hematopoietic stem-cell transplantation in accordance with sleep state", master, pp.2018
- Özkan S, "Evaluation of coping strategies, social support, and depressive symptoms in spouses of patients with hematological cancer", Turk J Med Sci, 40, pp.925~936 (2010)
- 배가령, "조혈모세포 이식 전 환자의사회적 지지, 희망, 불안 및 우울의 관계", 성인간호학회지, 28(1), pp.30~42 (2016), 한국성인간호학회[DOI]
- 심순희, "비호지킨 림프종 환자의 극복력이 삶의 질에 미치는 영향", Asian Oncology Nursing, 19(1), pp.47~54 (2019), 대한종양간호학회[DOI]
- Immanuel A, "Quality of life in survivors of adult haematological malignancy", Eur J Cancer Care (Engl), 28, pp.e13067~ (2019)